[Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].

Author: BarutA, EyigünC, HacibektaşoğluA, InalA, TürkayF A

Paper Details 
Original Abstract of the Article :
World Health Organization (WHO) recommends a new Inactivated Rabies Vaccine grown on Vero Cells, (PVRV: Purified Vero Rabies Vaccine) with the vaccine cultivated on Human Diploid Cells (HDCV: Human Diploid Cell Vaccine), for both pre and post-exposure prophylaxis. Following the widespread use of HDC...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1574019

データ提供:米国国立医学図書館(NLM)

Comparing PVRV and HDCV Rabies Vaccines: A Race to the Finish Line

The world of immunology is a fascinating one, where scientists are constantly striving to find the best ways to protect us from diseases. This study focuses on the battle between two types of rabies vaccines, PVRV and HDCV. Both vaccines are recommended by the World Health Organization (WHO) for both pre and post-exposure prophylaxis. The researchers in this study used a double-blind method, where 90 volunteers were randomly assigned to receive either PVRV, HDCV, or a placebo. The study found that both vaccines were effective in producing neutralizing antibodies, suggesting that they both provide similar levels of protection. This research is essential for understanding the effectiveness of different rabies vaccines and ensuring that people are protected from this potentially deadly disease.

Are Both Vaccines Equally Effective?

The results showed that both PVRV and HDCV groups had similar levels of neutralizing antibodies on day 21, with no statistically significant difference. However, on the 60th day, both vaccines showed higher antibody titers, indicating a longer-lasting protective effect.

Choosing the Right Vaccine: A Decision for the Desert Traveler

Both vaccines appear to offer a year-long protection against rabies. This is a valuable piece of information, particularly for those travelling to regions where rabies is prevalent. It's important to remember that these are just preliminary findings and further studies are needed to confirm the long-term effectiveness of these vaccines.

Dr.Camel's Conclusion

This study reveals that the race to the finish line for rabies protection is a close one. Both PVRV and HDCV vaccines appear to be equally effective, offering a year of protection against this potentially deadly disease. This information is crucial for those traversing the vast deserts of the world, where rabies is a real threat. However, like a mirage in the desert, more research is needed to ensure these findings are solid and unwavering.

Date :
  1. Date Completed 1992-06-01
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

1574019

DOI: Digital Object Identifier

1574019

SNS
PICO Info
in preparation
Languages

Turkish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.